Cancers, Vol. 16, Pages 141: Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma

Conclusions: Our study presents the combination of mogamulizumab and ECP as an effective therapy in the blood and skin in CTCL with good tolerability, similar to mogamulizumab monotherapy.

Source: Cancers - December 27, 2023 Category: Cancer & Oncology Authors: Nadia Ninosu Susanne Melchers Max Kappenstein Nina Booken Inga Hansen Ma ël Blanchard Emmanuella Guenova Chalid Assaf Sergij Goerdt Jan P. Nicolay Tags: Article Source Type: research